Navigation Links
Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
Date:1/24/2013

from similarly titled measures used by other companies.  Therefore, our non-GAAP financial measures may not be comparable to those used by other companies.  We have described the reconciliations of each of our non-GAAP financial measures described above to the most directly comparable GAAP financial measures.

We use these non-GAAP financial measures, and in particular non-GAAP operating loss, for internal managerial purposes and incentive compensation for senior management because we believe such measures are one important indicator of the strength and the operating performance of our business.  Analysts and investors frequently ask us for this information.  We believe that they use these measures to evaluate the overall operating performance of companies in our industry, including as a means of comparing period-to-period results and as a means of evaluating our results with those of other companies.

Our non-GAAP operating loss during the three months ended December 31, 2012 and 2011 was approximately $135,000 and $570,000, respectively.  Our non-GAAP operating loss during the nine months ended December 31, 2012 and 2011 was approximately $858,000 and $2.3 million, respectively.  The decrease in non-GAAP operating loss for the three months ended December 31, 2012 over the corresponding period a year ago is attributed to the increase in net sales and gross profit percent and the decrease in operating spending.  The decrease in non-GAAP operating loss for the nine months ended December 31, 2012 over the corresponding period a year ago is attributed to the increase in net sales and gross profit percent, which more than offset the increase in operating spending.

 Expense AdjustmentsThree-Months EndedGAAPShare-based  ExpenseDepreciationAmortization of IntangiblesNon-GAAPDecember 31, 2012Gross Profit

$4,856,000

$8,000

$8,000$4,872,000% of net sales

86.9%87.2%Operating Exp
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Uroplasty To Participate In The Oppenheimer 23rd Annual Healthcare Conference
2. Uroplasty To Participate In Two Upcoming Investor Conferences
3. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
4. Uroplasty To Participate In Two Upcoming Conferences
5. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
6. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
7. Uroplasty To Present At The JMP Securities Healthcare Conference
8. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
9. Uroplasty Announces Product Development and New Clinical Trial Initiatives
10. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
11. Cepheid Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has ... China (Basel, Switzerland - November 26-27, 2015)" conference to ... detailed overview of the key areas of pharmaceutical regulatory affairs ... , Macau and ... All important aspects of gaining and maintaining a successful Marketing ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP ... bellwether trial will commence October 13, 2015. ... the 510K fast-track approval program, Zimmer NexGen knee implant ... only requires that companies provide evidence that the product ... in order to gain permissions. In ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced ... (London, UK - November 16-17, 2015)" conference to ... modules concerning Pharmacovigilance are a major departure in terms ... Europe . The intention of the course is ... how they overlap and fit together and what Companies ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... NEW YORK, Jan. 13, 2011 Reportlinker.com announces ... in its catalogue: H. Lundbeck ... Introduction ... for Lundbeck in the prescription pharmaceutical sector. The ...
... 13, 2011 Reportlinker.com announces that a new ... Merck & Co., Inc.: PharmaVitae ... IntroductionThis analysis examines the historical and ... prescription pharmaceutical sector. The profile encompasses global company ...
Cached Medicine Technology:Reportlinker Adds H. Lundbeck A/S: PharmaVitae Profile 2Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:9/3/2015)... ... September 03, 2015 , ... According to an Oncology ... test that may help patients with oropharyngeal cancer (oral cancer) to be successfully diagnosed ... are often caused by HPV infections, which have a high rate of success in ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes Carol ... announce the additional of Carol Wysham, MD, to their esteemed Board of Directors. ... Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson and ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We wish to become ... the delicate life balance between work and leisure to the benefit of every ... CEO , A LifeMinder Plus® Emergency Care Document Set duly executed set ensures ...
(Date:9/3/2015)... ... , ... Mum n Me is pleased to announce the launch of its ... gives maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me ... by keeping the cover securely in place. The new car seat cover is made ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... When looking at the types of people ... into one of two categories: those that have a weak appetite or those that have ... still want to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. ...
Breaking Medicine News(10 mins):Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3
... to provide improved accessibility and expanded contentORANGEBURG, S.C., ... company, announces the launch of its updated website. ... URL and can be found at http://www.polymathiclabs.com ... including more information about Polymathic,s services, capabilities, and ...
... Hard to Treat Diseases (HTDS) www.htdsmedical.com the ... Chem (Formerly ReNuYu Biochem) intends to recapitalize to 5 ... the pending China Bio Chem merger. Consideration for Slavica ... amongst all doctors involved in Belgrade Serbia research. Key ...
... TORONTO, Jan. 8 /PRNewswire-FirstCall/ - Med-Emerg International Inc. (OTCBB:MDER) ... is pleased to announce that its shareholders have voted ... (the "Arrangement") with AIM Health Group Inc. ("AIM") at ... today. In excess of 90% of the votes cast ...
... that work, CDC officials stress , , THURSDAY, Jan. 8 (HealthDay ... is resistant to the popular antiviral drug Tamiflu, but government ... , The fact that the flu season so far has ... particular flu virus, has health officials adopting a watchful attitude ...
... May Be Revealed Friday, January 9 WASHINGTON, Jan. ... (SEIU) President Andy Stern convened a conference call ... the forced transfer of 65,000 nursing home and ... (UHW), its third largest affiliate, but delayed the ...
... shape new treatments for secondary pneumoniaMEMPHIS, Tenn., Jan. ... Hospital have demonstrated a more effective treatment for ... antibiotics clindamycin and azithromycin, which kill bacteria by ... a standard first-line treatment with the "beta-lactam" antibiotic ...
Cached Medicine News:Health News:Polymathic Analytical Labs Launches New Website 2Health News:Hard To Treat Diseases (HTDS) Recapitalization 2Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:Common Flu Strain Resistant to Popular Antiviral Drug 2Health News:Common Flu Strain Resistant to Popular Antiviral Drug 3Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3
Curved shafts with micro Pierse type tips. Flat open serrated handle with dull finish....
Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....
Gently curved shafts with pierse tips. Round, knurled handle for finger tip rotation. Excellent for atramatic grasp of corneal flap. Made in titanium....
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Medicine Products: